BioSpace News Archive

CSOFT Life Sciences Business Unit, MedL10N, a leading provider for pre-clinical to post-launch market consulting, product localization, and medical translation is sponsoring the Drug Information Association by providing live interpretation services at DIA China Annual Meeting 2019 from May 20 - 23 in Beijing

Crown Laboratories announced today that it is launching its new corporate branding, a result of significant business changes made this past year.

Today, 22 May 2019, the annual general meeting was held in AlzeCure Pharma AB (publ). Below is a summary of the resolutions made. All resolutions were passed with the required majority.

Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Kiadis Pharma N.V. (“Kiadis”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announced a strategic collaboration

Cheetah Medical, a Boston-based leader in non-invasive fluid management, today announced new results of two sepsis data analyses utilizing Cheetah Medical technology.

In honor of Military Appreciation Month, Desert Hope Treatment Center, an American Addiction Centers’ (NYSE: AAC) facility and leading provider of substance use treatment services, is providing a lifeline to the countless veterans who suffer in silence with drug and/or alcohol addiction and co-occurring mental health conditions.

AppTek, a leader in Artificial Intelligence, Machine Learning, Automatic Speech Recognition and Machine Translation, congratulates Dr. Hermann Ney, its Director of Science and the Chair of Human Language Technology and Pattern Recognition at RWTH Aachen University, for being presented with IEEE’s prestigious James Flanagan award for his lifetime of accomplishments in the automated speech recognition industry.

Puration, Inc. (USOTC: PURA) today confirmed management’s recent $4 million 2019 revenue target on growing demand for its cornerstone EVERx CBD Sports Water product.

Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Mallinckrodt plc (NYSE: MNK) common stock from April 13, 2016 through May 21, 2019.

The data-driven model sheds new light on mitosis, a critical process for human cells and a pivotal driver of cancer